Australia Launches Record A2 Billion Lawsuit Against 3M Over PFAS Contamination at Defence Sites Micron on Track for Best Monthly Rally Since 1987 Analysts Suggest Further Upside Potential IBM Shares Surge 27 Billion After Trump Administrations 2 Billion Quantum Computing Push Eli Lilly Reports Positive Phase 3 Results for Obesity Treatment Retatrutide Showcasing Significant Weight Reduction Chancellor Rachel Reeves Unveils VAT Cut on Summer Fun in CostofLiving Package ByteDance Reportedly Poised to Spend Up to 89 Billion in AI Expansion Amcor plc AMCR Q1 2026 Earnings EPS Misses Estimates Amid Cost Headwinds Akebia Therapeutics AKBA Q1 2026 Earnings EPS Misses Estimates Amid Quiet Trading Session First Citizens BancShares Inc FCNCA Q1 2026 Earnings Robust Earnings Beat Reflects Strong Operating Execution KOSS Q1 2026 Earnings Negative EPS and Stock Decline Highlight Persistent Headwinds WPM Q1 2026 Earnings EPS Surpasses Estimates by 23 Hyliion Holdings Corp HYLN Q1 2026 Earnings Narrower Loss Fuels 42 Rally Acumen Pharmaceuticals ABOS Slides 359 Testing NearTerm Support PayPal Holdings PYPL Stabilizes Near 44 as Market Gauges Growth Outlook Shoals Technologies SHLS Edges Higher Testing Key Support Levels Syntec Optics Holdings Warrant OPTXW Rallies 105 Key Resistance Test Ahead United Parks Resorts PRKS Gains 26 as Stock Approaches Key Resistance Level Qualcomm Enters Budget PC Chip Market as Semiconductor Supply Tightens LWLG Q3 2024 Earnings Continued RD Investment as Revenue Yet to Materialize Propanc Biopharma PPCB Edges Lower Amid Biotech Volatility GigaCloud Technology GCT Holds Steady Near Support Sideways Trading Signals Caution FFA Edges Lower Amidst Modest Decline Key Support and Resistance Levels in Focus AutoZone AZO Slips Modestly Testing Key Technical Levels Amid Mixed Sentiment Waldencast plc WALD Shows Resilience with 382 Gain Testing Key Resistance Steel Dynamics STLD Holds Steady Near 251 as Consolidated Trading Continues AN2 Therapeutics ANTX Slips Amid Biotech Sector Headwinds Key Support Levels in Focus Liminatus Pharma LIMN Plunges 31 as Support Level Approaches Key Levels to Watch